Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Br J Dermatol. 2017 Jul 31;177(4):1086–1092. doi: 10.1111/bjd.15596

Table 4.

Intra-rater reliability of Skin Assessment Tool Scores in JDM patients among pediatric specialists*

Within pediatric dermatologists (n=5) Within pediatric rheumatologists (n=5) Within pediatric neurologists (n=5)
CDASI
 Activity 0.90 (0.78–1.00) 0.91 (0.79–1.00) 0.65 (0.29–1.00)
 Damage 0.97 (0.94–1.00) 0.64 (0.27–1.00) 0.78 (0.53–1.00)
CAT-BM
 Activity 0.86 (0.70–1.00) 0.88 (0.74–1.00) 0.91 (0.80–1.00)
 Damage 0.93 (0.85–1.00) 0.73 (0.44–1.00) 0.89 (0.76–1.00)
Skin PGA
 Activity 0.95 (0.90–1.00) 0.50 (0.03–0.96) 0.83 (0.64–1.00)
 Damage 0.84 (0.66–1.00) 0.55 (0.12–0.98) 0.96 (0.91–1.00)
*

Intra-class correlation coefficients (95% C.I.)

Abbreviations: CDASI: Cutaneous Dermatomyositis Disease Area and Severity Index; CAT-BM: Cutaneous Assessment Tool-Binary Method; PGA: Physician Global Assessment

Summary: The intra-rater agreement was excellent for pediatric dermatologists using the CDASI and CAT-BM measures, and the intra-rater agreement was good to excellent for pediatric rheumatologists and neurologists using the same outcome instruments.